Showing results (241-250 of 343) with videos related to
Sort By:
Pageof 35
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 29, 2011
Ambrisentan for sarcoidosis associated pulmonary hypertensionM A Judson, K B Highland, S Kwon, et al.Respiratory Medicine|May 16, 2021
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)Ogugua Ndili Obi, Marc A Judson, Surinder S Birring, et al.Critical Care Medicine|April 1, 1988
Patient selection for intensive care: a comparison of New Zealand and United States hospitalsJ E Zimmerman, W A Knaus, J A Judson, et al.Respiratory Medicine|May 27, 2019
Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosisMarc A Judson, Sara Preston, Kurt Hu, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 31, 2002
Use of fluticasone in acute symptomatic pulmonary sarcoidosisRobert P Baughman, Michael C Iannuzzi, Elyse E Lower, et al.Immunology|March 1, 1992
New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytesA Fletcher, J A Bryant, B Gardner, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 10, 2018
High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosisMegan H Noe, Olaf Rodriguez, Laura Taylor, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 6, 2016
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trialRobert P Baughman, Marc A Judson, Elyse E Lower, et al.The American Journal of Medicine|November 22, 2019
Cannabinoid Oil Vaping-Associated Lung Injury and its Radiographic AppearanceEdward J Conuel, Hau C Chieng, John Fantauzzi, et al.The American Journal of the Medical Sciences|August 31, 2011
Neurological deficits during treatment with tumor necrosis factor-alpha antagonistsKenkichi Nozaki, Richard M Silver, David E Stickler, et al.Pageof 35